These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 393712)

  • 1. Compatible results obtained from biotyping and serotyping in Serratia marcescens.
    Grimont PA; Grimont F; Le Minor S; Davis B; Pigache F
    J Clin Microbiol; 1979 Oct; 10(4):425-32. PubMed ID: 393712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-antibiotic effect of imipenem, amikacin and ciprofloxacin against various strains of Serratia marcescens].
    Bollet C; Mallet MN; Bouchemal H; de Micco P
    Pathol Biol (Paris); 1990 May; 38(5):446-9. PubMed ID: 2195454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system.
    Sifuentes-Osornio J; Ruiz-Palacios GM; Gröschel DH
    J Clin Microbiol; 1986 Feb; 23(2):230-4. PubMed ID: 3517048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved O-serotyping method for Serratia marcescens.
    Gaston MA; Pitt TL
    J Clin Microbiol; 1989 Dec; 27(12):2702-5. PubMed ID: 2480362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes.
    Aucken HM; Pitt TL
    J Med Microbiol; 1998 Dec; 47(12):1105-13. PubMed ID: 9856647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotyping of Serratia marcescens and its use in epidemiological studies.
    Grimont PA; Grimont F
    J Clin Microbiol; 1978 Jul; 8(1):73-83. PubMed ID: 353073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-antigen specificities of the serotype strains of Serratia marcescens.
    Gaston MA; Pitt TL
    J Clin Microbiol; 1989 Dec; 27(12):2697-701. PubMed ID: 2480361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined serotyping and biotyping of Serratia marcescens.
    Rubin SJ; Brock S; Chamberland M; Lyons RW
    J Clin Microbiol; 1976 Jun; 3(6):582-5. PubMed ID: 780372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotyping of Serratia marcescens using passive haemagglutination.
    Guinée PA; Jansen WH; Maas HM
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):105-19. PubMed ID: 2442923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serratia marcescens infections in a hospital: typing of isolated strains].
    Yde M
    Arch Belg; 1989; 47(5-6):189-210. PubMed ID: 2700064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological evaluation of Serratia marcescens clinical isolates in a general hospital during the past three years: appearance of O-antigens O2 and O14].
    Marumo K; Nakamura Y; Sakurai C
    Rinsho Byori; 1998 Jul; 46(7):728-33. PubMed ID: 9721543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different O and K serotype distributions among clinical and environmental strains of Serratia marcescens.
    Aucken HM; Pitt TL
    J Med Microbiol; 1998 Dec; 47(12):1097-104. PubMed ID: 9856646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotyping of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C; Cruz-Camarillo R
    Rev Latinoam Microbiol; 1992; 34(4):253-8. PubMed ID: 1345114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [O-serotypes, biotypes and antimicrobial susceptibilities of Serratia marcescens isolates from clinical specimens: 4th report].
    Marumo K; Nakamura Y; Fukuda S
    Rinsho Byori; 1995 Nov; 43(11):1140-6. PubMed ID: 8551678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic study of "Serratia marcescens" isolated in France.II.--Characterization of O antigens and description of 5 new O factors, occurrence of serotypes and labelling of new H factors (author's transl)].
    Le Minor S; Pigache F
    Ann Microbiol (Paris); 1978 Oct; 129 B(3):407-23. PubMed ID: 85425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens.
    Alonso R; Aucken HM; Perez-Diaz JC; Cookson BD; Baquero F; Pitt TL
    Epidemiol Infect; 1993 Aug; 111(1):99-107. PubMed ID: 8102336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriocin typing and biotyping of clinical isolates of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):474-86. PubMed ID: 1755921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [O-serotypes, biotypes, and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens: 3rd report].
    Marumo K; Nagaki T; Nakamura Y
    Rinsho Byori; 1992 Dec; 40(12):1312-8. PubMed ID: 1307637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotyping of Serratia marcescens: simplified tube O-agglutination test and comparison with other serological procedures.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):474-93. PubMed ID: 396741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation rate of non-hemagglutinating strains of Serratia marcescens from clinical specimens in a general hospital: comparison of serotypes O2 and O14.
    Yanagawa Y; Marumo K; Nakamura Y; Shimamura T
    J Infect Chemother; 2007 Jun; 13(3):151-6. PubMed ID: 17593501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.